These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 7431981

  • 21. Six years' experience with the Omnicarbon valve prosthesis.
    Otaki M, Kitamura N.
    Cardiovasc Surg; 1993 Oct; 1(5):594-8. PubMed ID: 8076103
    [Abstract] [Full Text] [Related]

  • 22. Five- to eight-year follow-up of patients with the Hancock cardiac bioprosthesis.
    Gallo I, Ruiz B, Duran CM.
    J Thorac Cardiovasc Surg; 1983 Dec; 86(6):897-902. PubMed ID: 6645592
    [Abstract] [Full Text] [Related]

  • 23. Mid-term results after Epic xenograft implantation for aortic, mitral, and double valve replacement.
    Lehmann S, Walther T, Leontjev S, Kempfert J, Rastan A, Garbade J, Borger MA, Falk V, Mohr FW.
    J Heart Valve Dis; 2007 Nov; 16(6):641-8; discussion 648. PubMed ID: 18095514
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evaluation of valve-related complications in patients with Sorin Bicarbon prosthesis: a seven-year experience.
    Bortolotti U, Milano A, D'Alfonso A, Piccin C, Mecozzi G, Magagna P, Fabbri A, Mazzucco A.
    J Heart Valve Dis; 2001 Nov; 10(6):795-801. PubMed ID: 11767189
    [Abstract] [Full Text] [Related]

  • 26. Long-term outcomes of valve replacement with modern prostheses in young adults.
    Ruel M, Kulik A, Lam BK, Rubens FD, Hendry PJ, Masters RG, Bédard P, Mesana TG.
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):425-33; discussion 433. PubMed ID: 15740951
    [Abstract] [Full Text] [Related]

  • 27. Early clinical experience with the On-X prosthetic heart valve.
    Laczkovics A, Heidt M, Oelert H, Laufer G, Greve H, Pomar JL, Mohr FW, Haverich A, Birnbaum D, Regensburger D, Palatianos G, Wolner E.
    J Heart Valve Dis; 2001 Jan; 10(1):94-9. PubMed ID: 11206775
    [Abstract] [Full Text] [Related]

  • 28. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I, Lip GY, Mukundan S, Rosin MD.
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [Abstract] [Full Text] [Related]

  • 29. The Mitroflow pericardial valve: clinical performance to 10 years.
    Mazzucotelli JP, Bertrand PC, Loisance DY.
    J Heart Valve Dis; 1995 Jul; 4(4):407-13. PubMed ID: 7582152
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The Ultracor tilting disc heart valve prosthesis: a seven-year study.
    Li HH, Jeffrey RR, Davidson KG, Seifert D, Körfer R, Grunkemeier GL.
    J Heart Valve Dis; 1998 Nov; 7(6):647-54. PubMed ID: 9870199
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The mosaic valve clinical performance at seven years: results from a multicenter prospective clinical trial.
    Fradet G, Bleese N, Busse E, Jamieson E, Raudkivi P, Goldstein J, Metras J.
    J Heart Valve Dis; 2004 Mar; 13(2):239-46; discussion 246-7. PubMed ID: 15086263
    [Abstract] [Full Text] [Related]

  • 34. [Late results of mitral valve replacement with porcine bioprosthesis].
    Aoyagi S, Tanaka K, Hara H, Kosuga K, Oishi K.
    Rinsho Kyobu Geka; 1989 Aug; 9(4):343-6. PubMed ID: 9301939
    [Abstract] [Full Text] [Related]

  • 35. Results and complications with the Omniscience prosthesis.
    Rábago G, Martinell J, Fraile J, Andrade IG, Montenegro R.
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):136-40. PubMed ID: 6690851
    [Abstract] [Full Text] [Related]

  • 36. Chitra heart valve: results of a multicenter clinical study.
    Sankarkumar R, Bhuvaneshwar GS, Magotra R, Muralidharan S, Rajan RS, Saha D, Subba Rao KS, Valiathan MS, Radhakrishna S, Ramani AV.
    J Heart Valve Dis; 2001 Sep; 10(5):619-27. PubMed ID: 11603602
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the causes of late death following aortic and mitral valve replacement. VA Co-operative Study on Valvular Heart Disease.
    Hwang MH, Burchfiel CM, Sethi GK, Oprian C, Grover FL, Henderson WG, Hammermeister K.
    J Heart Valve Dis; 1994 Jan; 3(1):17-24. PubMed ID: 8162209
    [Abstract] [Full Text] [Related]

  • 38. Long-term outcome after valve replacement with the omnicarbon prosthesis.
    di Summa M, Poletti G, Brero L, Centofanti P, La Torre M, Patanè F, Raggio JM, Sanchez FG, Maroñas JM, Torregrosa S, Valera FJ, Caffarena J.
    J Heart Valve Dis; 2002 Jul; 11(4):517-23. PubMed ID: 12150300
    [Abstract] [Full Text] [Related]

  • 39. [Surgical results of valve replacement with porcine bioprostheses].
    Saigenji H, Toyohira H, Shimokawa S, Moriyama Y, Watanabe S, Yamashita T, Yamaoka A, Yuda T, Toda R, Taira A.
    Nihon Kyobu Geka Gakkai Zasshi; 1996 May; 44(5):634-40. PubMed ID: 8964992
    [Abstract] [Full Text] [Related]

  • 40. Actuarial versus actual freedom from structural valve deterioration with the Carpentier-Edwards porcine bioprostheses.
    Jamieson WR, Burr LH, Miyagishima RT, Germann E, Anderson WN.
    Can J Cardiol; 1999 Sep; 15(9):973-8. PubMed ID: 10504178
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.